Drug firm Divi's Laboratories on Monday said its profit after tax (PAT) increased 65 per cent to Rs 589 crore for the ...

In the corresponding quarter of the previous fiscal, Alembic Pharmaceuticals posted a net profit of ₹180.4 crore. The company ...

A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North ...

In an exchange filing last month, the company had informed that a meeting of its Board of Directors is scheduled for this ...

The stock was last seen trading 5.18 per cent up at Rs 8,415.85. At this price, it has climbed 13.55 per cent in the past one ...

Alembic Pharmaceuticals reported a 23.29% decline in Q3 FY25 net profit at ₹138.42 crore, despite a 3.81% revenue increase to ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

MercadoLibre has robust growth with significant ad revenue gains. See why MELI stock's high P/E ratio is justified, and why ...

Despite Reddit's strong fundamentals and network effects, valuation appears 50% too high. Learn why RDDT stock is a Sell.

For three quarters running, Alphabet (Nasdaq: GOOG) (Nasdaq: GOOGL) has surprised and delighted its shareholders with ...

We recently published a list of Why These 15 Industrial Stocks Are Skyrocketing So Far In 2025. In this article, we are going ...

We recently published a list of Why These 15 Industrial Stocks Are Skyrocketing So Far In 2025. In this article, we are going ...